@article{1f21f273f84b4d65903a443ce00d9b7b,
title = "Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study",
keywords = "FOLLOW-UP, PLACEBO, EGPA, SAFETY",
author = "A. Bettiol and M.L. Urban and L. Dagna and V. Cottin and F. Franceschini and {Del Giacco}, S. and F. Schiavon and T. Neumann and G. Lopalco and P. Novikov and C. Baldini and C. Lombardi and A. Berti and F. Alberici and M. Folci and S. Negrini and R.A. Sinico and L. Quartuccio and C. Lunardi and P. Parronchi and F. Moosig and G. Espigol-Frigole and J. Schroeder and A.L. Kernder and S. Monti and E. Silvagni and C. Crimi and F. Cinetto and P. Fraticelli and D. Roccatello and A. Vacca and A.J. Mohammad and B. Hellmich and M. Samson and E. Bargagli and J.W.C. Tervaert and C. Ribi and D. Fiori and F. Bello and F. Fagni and L. Moroni and G.A. Ramirez and M. Nasser and C. Marvisi and P. Toniati and D. Firinu and R. Padoan and A. Egan and B. Seeliger and {European EGPA Study Group} and Giacomo Emmi",
year = "2022",
month = feb,
doi = "10.1002/art.41943",
language = "English",
volume = "74",
pages = "295--306",
journal = "Arthritis & Rheumatology",
issn = "2326-5191",
publisher = "Wiley",
number = "2",
}